| Mon, 15 Jul 2019 13:42:38: | Free of Pfizer, AM-Pharma raises €116M for phase 3
|
| Mon, 15 Jul 2019 13:03:21: | Could Karyopharm's newly approved multiple myeloma drug also work in glioblastoma?
|
| Mon, 15 Jul 2019 12:46:43: | AbbVie jumps into STING cancer work with Mavupharma buy
|
| Mon, 15 Jul 2019 12:45:50: | J&J gears up for clinical test of HIV vaccine efficacy
|
| Mon, 15 Jul 2019 12:24:12: | Boehringer buys up cancer vaccine player, eyes oncology combo strategy
|
| Mon, 15 Jul 2019 08:20:02: | Gilead inks $5B upfront deal to gain broad access to Galapagos' pipeline
|
| Fri, 12 Jul 2019 10:27:04: | Sofinnova invests in Abivax to delay cash crunch
|
| Fri, 12 Jul 2019 07:54:07: | Weak data spur Amgen, Novartis to can pivotal Alzheimer's test
|
| Thu, 11 Jul 2019 19:07:44: | Chutes & Ladders—Former Merrimack CEO becomes new chief at Yumanity
|
| Thu, 11 Jul 2019 15:08:48: | Boosting CAR-T to treat solid tumors with a vaccine
|
| Thu, 11 Jul 2019 13:32:22: | CRISPR pioneer Zhang targets brain diseases with new RNA-editing system
|
| Thu, 11 Jul 2019 11:46:17: | Tiaki hires Bruhn as CEO for Alzheimer's drug discovery push
|
| Thu, 11 Jul 2019 10:33:37: | GSK hires Branson from Genentech to boost AI team
|
| Thu, 11 Jul 2019 08:24:38: | Parexel closes San Diego office, axes 3 and offers others work-from-home roles
|
| Wed, 10 Jul 2019 12:53:11: | After exiting troubled Merrimack, former CEO becomes new chief at Yumanity
|
| Wed, 10 Jul 2019 09:50:44: | Could the 'hunger hormone' boost memory?
|
| Wed, 10 Jul 2019 08:56:03: | Charles River plots 2020 opening of South San Francisco lab
|
| Wed, 10 Jul 2019 06:00:38: | FDA accepts BLA filing for Sanofi's rival to J&J's Darzalex
|
| Tue, 09 Jul 2019 15:47:14: | Osivax raises €8M for universal flu vaccine clinical trials
|
| Tue, 09 Jul 2019 14:29:48: | Eisai launches first startup incubator under its genomics center for dementia
|
| Tue, 09 Jul 2019 12:38:51: | China's biotech cash injection suddenly drops as U.S. scrutiny intensifies: report
|
| Tue, 09 Jul 2019 11:40:34: | Celgene bags option on Nimbus' anticancer HPK1 inhibitor
|
| Mon, 08 Jul 2019 13:12:17: | Engineered bacteria prime solid tumors for immunotherapy
|
| Mon, 08 Jul 2019 11:50:58: | New data boost Pfizer, Sangamo hemophilia A gene therapy
|
| Mon, 08 Jul 2019 11:39:45: | Skyhawk Therapeutics nabs Peloton exec and cancer R&D veteran as VP of oncology biology
|
